Guizhou Bailing Group Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Guizhou Bailing Group Pharmaceutical has a total shareholder equity of CN¥3.5B and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 51.4%. Its total assets and total liabilities are CN¥7.2B and CN¥3.7B respectively.
Key information
51.4%
Debt to equity ratio
CN¥1.80b
Debt
Interest coverage ratio | n/a |
Cash | CN¥170.62m |
Equity | CN¥3.49b |
Total liabilities | CN¥3.66b |
Total assets | CN¥7.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002424's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥3.4B).
Long Term Liabilities: 002424's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥266.7M).
Debt to Equity History and Analysis
Debt Level: 002424's net debt to equity ratio (46.6%) is considered high.
Reducing Debt: 002424's debt to equity ratio has reduced from 54.7% to 51.4% over the past 5 years.
Debt Coverage: 002424's debt is not well covered by operating cash flow (8.8%).
Interest Coverage: Insufficient data to determine if 002424's interest payments on its debt are well covered by EBIT.